• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对 COVID-19 的潜在抗病毒免疫反应:从 SARS-CoV 中吸取的教训。

Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.

机构信息

Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

出版信息

Adv Exp Med Biol. 2021;1318:149-167. doi: 10.1007/978-3-030-63761-3_9.

DOI:10.1007/978-3-030-63761-3_9
PMID:33973177
Abstract

Virus and host innate immune system interaction plays a significant role in forming the outcome of viral diseases. Host innate immunity initially recognizes the viral invasion and induces a rapid inflammatory response, and this recognition activates signaling cascades that trigger the release of antiviral mediators. This chapter aims to explore the mechanisms by which newly emerged coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activates the host immune system. Since SARS-CoV-2 shares similarities with SARS-CoV that caused the epidemic of SARS in 2003, the pathogenesis of both viruses could be at least very similar. For this, this chapter provides a synthesis of literature concerning antiviral immunity in SARS-CoV and SARS-CoV-2. It includes the presentation of epitopes linked to SARS-CoV-2 as well as the ability of SARS-CoV-2 to cause proteolytic activation and interact with angiotensin-converting enzyme 2 (ACE2) via molecular mimicry. This chapter characterizes various mechanisms that this virus may engage in escaping the host immunity, ended by a discussion of humoral immune responses against SARS-CoV-2.

摘要

病毒和宿主固有免疫系统的相互作用在形成病毒疾病的结果方面起着重要作用。宿主固有免疫最初识别病毒入侵并诱导快速炎症反应,这种识别激活信号级联反应,触发抗病毒介质的释放。本章旨在探讨新型冠状病毒(称为严重急性呼吸综合征冠状病毒 2,SARS-CoV-2)激活宿主免疫系统的机制。由于 SARS-CoV-2 与 2003 年引起 SARS 流行的 SARS-CoV 具有相似性,因此两种病毒的发病机制至少非常相似。为此,本章综合了有关 SARS-CoV 和 SARS-CoV-2 抗病毒免疫的文献。它包括与 SARS-CoV-2 相关的表位的介绍,以及 SARS-CoV-2 通过分子模拟引起蛋白水解激活和与血管紧张素转换酶 2(ACE2)相互作用的能力。本章描述了该病毒可能逃避宿主免疫的各种机制,最后讨论了针对 SARS-CoV-2 的体液免疫反应。

相似文献

1
Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.针对 COVID-19 的潜在抗病毒免疫反应:从 SARS-CoV 中吸取的教训。
Adv Exp Med Biol. 2021;1318:149-167. doi: 10.1007/978-3-030-63761-3_9.
2
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.SARS-CoV-2 策略性地模拟人类 ENaC 的蛋白水解激活。
Elife. 2020 May 26;9:e58603. doi: 10.7554/eLife.58603.
3
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.计算机模拟研究阿奇霉素、氯喹和羟氯喹及其对 SARS-CoV-2 感染的潜在作用机制。
Int J Antimicrob Agents. 2020 Sep;56(3):106119. doi: 10.1016/j.ijantimicag.2020.106119. Epub 2020 Jul 30.
4
Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection.cGAS 对细胞质染色质的感应激活了 SARS-CoV-2 感染中的先天免疫反应。
Signal Transduct Target Ther. 2021 Nov 3;6(1):382. doi: 10.1038/s41392-021-00800-3.
5
Immunopathogenesis and immunobiology of SARS-CoV-2.SARS-CoV-2 的免疫发病机制和免疫生物学。
Infez Med. 2021 Jun 1;29(2):167-180.
6
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.竞争性 SARS-CoV-2 血清学研究表明,大多数针对刺突受体结合域的抗体竞争与 ACE2 结合。
mSphere. 2020 Sep 16;5(5):e00802-20. doi: 10.1128/mSphere.00802-20.
7
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.SARS-CoV-2 逃避宿主抗病毒先天免疫的分子机制。
Virol J. 2022 Mar 19;19(1):49. doi: 10.1186/s12985-022-01783-5.
8
Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.血管紧张素转化酶 2 和蛋白酶在 COVID-19 患者中的表达:细胞 FURIN 在 SARS-CoV-2 发病机制中的潜在作用。
Med Hypotheses. 2020 Oct;143:109893. doi: 10.1016/j.mehy.2020.109893. Epub 2020 May 30.
9
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.新型冠状病毒特异性免疫应答与 COVID-19 发病机制。
Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716.
10
Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an hACE2 transfection mouse model.中性粒细胞趋化因子 CXCL5 在 hACE2 转染小鼠模型 SARS-CoV-2 感染诱导的肺部炎症性先天免疫反应中的作用。
Zool Res. 2020 Nov 18;41(6):621-631. doi: 10.24272/j.issn.2095-8137.2020.118.

引用本文的文献

1
Mental Healthcare in Pediatrics During the COVID-19 Pandemic: A Call for International Public Health Action.儿科心理健康保健在 COVID-19 大流行期间:呼吁国际公共卫生行动。
Adv Exp Med Biol. 2024;1458:19-34. doi: 10.1007/978-3-031-61943-4_2.
2
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.新型冠状病毒肺炎被动免疫治疗的最新进展:基于证据的方法和临床试验。
Int Immunopharmacol. 2022 Aug;109:108786. doi: 10.1016/j.intimp.2022.108786. Epub 2022 Apr 21.
3
Autoinflammatory Diseases and Cytokine Storms-Imbalances of Innate and Adaptative Immunity.

本文引用的文献

1
Immunology of COVID-19: Current State of the Science.COVID-19 的免疫学:科学现状。
Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6.
2
Potential SARS-CoV-2 Preimmune IgM Epitopes.潜在的 SARS-CoV-2 预免疫 IgM 表位。
Front Immunol. 2020 Apr 30;11:932. doi: 10.3389/fimmu.2020.00932. eCollection 2020.
3
A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.一种新型蝙蝠冠状病毒与 SARS-CoV-2 密切相关,其 Spike 蛋白 S1/S2 裂解位点存在天然插入。
自身炎症性疾病和细胞因子风暴:固有免疫和适应性免疫失衡。
Int J Mol Sci. 2021 Oct 18;22(20):11241. doi: 10.3390/ijms222011241.
Curr Biol. 2020 Jun 8;30(11):2196-2203.e3. doi: 10.1016/j.cub.2020.05.023. Epub 2020 May 11.
4
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.新型冠状病毒感染恢复期个体中 SARS-CoV-2 特异性体液和细胞免疫的检测。
Immunity. 2020 Jun 16;52(6):971-977.e3. doi: 10.1016/j.immuni.2020.04.023. Epub 2020 May 3.
5
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.SARS-CoV-2 IgG 抗体在 COVID-19 男女性患者中的对比研究:性别间不同结局的潜在原因。
J Med Virol. 2020 Oct;92(10):2050-2054. doi: 10.1002/jmv.25989. Epub 2020 May 22.
6
Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.SARS-CoV-2 潜在 T 细胞表位的生物信息学预测。
J Hum Genet. 2020 Jul;65(7):569-575. doi: 10.1038/s10038-020-0771-5. Epub 2020 May 6.
7
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020).针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其他人类冠状病毒的中和抗体:(《免疫学趋势》第41卷,第355 - 359页;2020年)
Trends Immunol. 2020 Jun;41(6):545. doi: 10.1016/j.it.2020.04.008. Epub 2020 Apr 24.
8
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.SARS-CoV-2 刺突蛋白中的多碱性裂解位点对于感染人肺细胞至关重要。
Mol Cell. 2020 May 21;78(4):779-784.e5. doi: 10.1016/j.molcel.2020.04.022. Epub 2020 May 1.
9
COVID-19: Immunology and treatment options.新型冠状病毒肺炎:免疫学与治疗选择。
Clin Immunol. 2020 Jun;215:108448. doi: 10.1016/j.clim.2020.108448. Epub 2020 Apr 27.
10
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.